European Journal of Pediatrics

, Volume 164, Issue 12, pp 758–767 | Cite as

Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial

  • Heiner Frei
  • Regula Everts
  • Klaus von Ammon
  • Franz Kaufmann
  • Daniel Walther
  • Shu-Fang Hsu-Schmitz
  • Marco Collenberg
  • Katharina Fuhrer
  • Ralph Hassink
  • Maja SteinlinEmail author
  • André ThurneysenEmail author
Original Paper


An increasing number of parents turn to homeopathy for treatment of their hyperactive child. Two publications, a randomised, partially blinded trial and a clinical observation study, conclude that homeopathy has positive effects in patients with attention deficit hyperactivity disorder (ADHD). The aim of this study was to obtain scientific evidence of the effectiveness of homeopathy in ADHD. A total of 83 children aged 6–16 years, with ADHD diagnosed using the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, were recruited. Prior to the randomised, double blind, placebo controlled crossover study, they were treated with individually prescribed homeopathic medications. 62 patients, who achieved an improvement of 50% in the Conners’ Global Index (CGI), participated in the trial. Thirteen patients did not fulfill this eligibility criterion (CGI). The responders were split into two groups and received either verum for 6 weeks followed by placebo for 6 weeks (arm A), or vice-versa (arm B). At the beginning of the trial and after each crossover period, parents reported the CGI and patients underwent neuropsychological testing. The CGI rating was evaluated again at the end of each crossover period and twice in long-term follow-up. At entry to the crossover trial, cognitive performance such as visual global perception , impulsivity and divided attention, had improved significantly under open label treatment ( P<0.0001). During the crossover trial, CGI parent–ratings were significantly lower under verum (average 1.67 points) than under placebo ( P =0.0479). Long-term CGI improvement reached 12 points (63%, P <0.0001). Conclusion:The trial suggests scientific evidence of the effectiveness of homeopathy in the treatment of attention deficit hyperactivity disorder, particularly in the areas of behavioural and cognitive functions.


Attention deficit hyperactivity disorder Homeopathy Individualised treatment Randomised double blind trial Treatment effectiveness 



attention deficit hyperactivity disorder


Conners’ global index


Conners’ parent rating scale (long form)


Conners teacher rating scale


diagnostic and statistical manual of mental disorders


Kaufman assessment battery for children


questionnaire of change of behaviour


test battery for attention performance


German version of the Rey auditory verbal learning test (RAVLT)


German version of Wechsler intelligence scale for children



We sincerely thank all patients and families who took part in this trial for the enormous amount of time they sacrificed for travelling, testing and treatment sessions as well as for their patience in observing symptoms. Sincere thanks also to Jacqueline Ryffel and her staff at Spagyros for preparing and mailing the medications and placebos to the patients. Many thanks to Martina Frei for her contribution in the starting phase of the study and to Carol Lim for her substantial help in the preparation of the manuscript. This study was financed by grants of the following foundations and institutions: Gertrude von Meissner Foundation, Basel; Software AG Foundation, Darmstadt; Hans Eggenberger Foundation, Zürich; SNE Foundation, Solothurn; Fondation Homéopathie Pierre Schmidt Genève; PanMedion Foundation, Zürich; Spagyros AG, Gümligen; Gudjons Laboratory, Stadtbergen; Swiss Federal Railways (SBB), Berne.


  1. 1.
    Allen TF (1990) The Encyclopaedia of Pure Materia Medica, vol.. Jain, New DelhiGoogle Scholar
  2. 2.
    American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, DSM-IV, 4th edn. American Psychiatric Association, Washington,Google Scholar
  3. 3.
    von Bönninghausen C (2000) Bönninghausens therapeutisches Taschenbuch, revidierte Ausgabe. Hrsg. K-H. Gypser, StuttgartGoogle Scholar
  4. 4.
    Brown H, Prescott R (1999) Applied mixed models in medicine. Wiley, Chichester, pp 261–294Google Scholar
  5. 5.
    Brue AW, Oakland TD (2002) Alternative treatments for attention deficit/hyperactivity disorder: does evidence support their use? Altern Ther Health Med 8: 68–74Google Scholar
  6. 6.
    Carte ET, Nigg JT, Hinshaw SP (1996) Neuropsychological functioning, motor speed, and language processing in boys with and without ADHD. J Abnorm Child Psychol 24: 481–498PubMedGoogle Scholar
  7. 7.
    Conners CK(1997) Conners rating scales (revised), technical manual. MHS, TorontoGoogle Scholar
  8. 8.
    Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. Brit Hom J 2001; 90: 183–188.Google Scholar
  9. 9.
    Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21: 467–480PubMedGoogle Scholar
  10. 10.
    Gross-Tsur V, Lahad A, Shalev R (2003) Use of complementary medicine in children with attention deficit hyperactivity disorder and epilepsy. Pediatr Neurol 29: 53–55PubMedGoogle Scholar
  11. 11.
    Hahnemann CFS (1989) Organon der Heilkunst, 6th edn. Haug, HeidelbergGoogle Scholar
  12. 12.
    Helmstaedter C, Lendt M, Lux S (2001) Verbaler Lern- und Merkfähigkeitstest (VLMT). Beltz Test Gmbh, GöttingenGoogle Scholar
  13. 13.
    Kaufman AS, Kaufman NL (1983) Kaufman Assessment Battery for Children (K-ABC). AGS Publishing, Circle PinesGoogle Scholar
  14. 14.
    Kinsbourne M (1973) School problems. Paediatrics 52: 679–710Google Scholar
  15. 15.
    Kleijnen J, Knipschild P (1991) Clinical trials of homeopathy. BMedJ 302: 316–323Google Scholar
  16. 16.
    Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151: 1673–1685PubMedGoogle Scholar
  17. 17.
    Lamont J (1997) Homeopathic treatment of attention deficit disorder. Br Hom J 86: 196–200Google Scholar
  18. 18.
    Largo R (1993) Zürcher neuromotorische Untersuchung. Abteilung für Wachstum und Entwicklung, Universitäts-Kinderklinik, ZürichGoogle Scholar
  19. 19.
    Lattmann P, Schneider A (1995) Informationen für den Prüfer zur Durchführung klinischer Versuche mit Heilmitteln in der Schweiz. SGCI, ZürichGoogle Scholar
  20. 20.
    Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB (1997) Are the clinical effects of homeopathy placebo effects? A meta-analysis of controlled trials. Lancet 350: 834–843PubMedGoogle Scholar
  21. 21.
    Mehta MA, Goodyer IM, Sahakian BJ (2004) Methylphenidate improves working memory and set shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45: 293–305PubMedGoogle Scholar
  22. 22.
    Minder P (2003) The Q-potencies, a comprehensive and profound way of medication in homeopathy. Schweiz Zschr GanzheitsMedizin 15: 348–353Google Scholar
  23. 23.
    Seidman LJ, Biederman J, Monuteaux MC, Weber W, Faraone SV (2000) Neuropsychological functioning in nonreferred siblings of children with attention deficit/hyperactivity disorder. J Abnorm Psychol 109: 252–265PubMedGoogle Scholar
  24. 24.
    Senn S (1993) Cross-over Trials in Clinical Research. Wiley, Chichester, pp 12–13Google Scholar
  25. 25.
    Snyder SM, John F, Xenakis SN (2004) Validation of ADHD rating scales. J Am Acad Child Adolesc Psychiatry 43: 1189–1190CrossRefGoogle Scholar
  26. 26.
    Stewart-Williams S, Podd J (2004) The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 130: 324–340PubMedGoogle Scholar
  27. 27.
    Tewes U, Schallberger U, Rossmann K (1999) Hamburg Wechsler Intelligenztest für Kinder III (HAWIK-III). Hogrefe, GöttingenGoogle Scholar
  28. 28.
    Verbeke G, Molenberghs G (1997) Linear mixed models in practice. Springer, Berlin Heidelberg New YorkGoogle Scholar
  29. 29.
    World Medical Association (2002) Declaration of Helsinki. WashingtonGoogle Scholar
  30. 30.
    Zimmermann P, Fimm B (1992) Testbatterie zur Aufmerksamkeitsprüfung TAP, Handbuch. Psychologische Testsysteme PsyTest, FreiburgGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Heiner Frei
    • 1
  • Regula Everts
    • 2
  • Klaus von Ammon
    • 3
  • Franz Kaufmann
    • 2
  • Daniel Walther
    • 2
  • Shu-Fang Hsu-Schmitz
    • 4
  • Marco Collenberg
    • 4
  • Katharina Fuhrer
    • 2
  • Ralph Hassink
    • 5
  • Maja Steinlin
    • 2
    Email author
  • André Thurneysen
    • 3
    Email author
  1. 1.Swiss Association of Homeopathic Physicians SAHPLucerne Switzerland
  2. 2.Division of Paediatric NeurologyUniversity Children’s Hospital, InselspitalBerne Switzerland
  3. 3.Kollegiale Instanz für Komplementärmedizin (KIKOM)/HomeopathyImhoof Pavillon, InselspitalBerne Switzerland
  4. 4.Department of Mathematical Statistics and Actuarial Science (IMSV)University of BerneBerne Switzerland
  5. 5.Zentrum für Entwicklungsförderung und pädiatrische NeurorehabilitationBienne Switzerland

Personalised recommendations